Cardiomyopathy and encephalopathy in AIDS

Annals of the New York Academy of Sciences

Volumn 946, Issue , 2001, Pages 121-129

  Antinori, Andrea ^a   Giancola, Maria Letizia ^a   Alba, Lucia ^a   Soldani, Fabio ^a   Grisetti, Susanna ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Antiretroviral therapy; Cardiomyopathy; HIV; HIV dementia; Inducible nitric oxide synthase; TNF

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; NEUROTOXIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ASTROCYTOSIS; BRAIN DISEASE; CARDIOMYOPATHY; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; DEMENTIA; DEMYELINATION; MULTINUCLEAR CELL; SURVIVAL; VIRUS REPLICATION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035202432     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03907.x     Document Type: Conference Paper

References (32)

1. Temporal trends in the incidents of HIV-1 related neurologic diseases
2. The brain and AIDS: Central nervous system HIV-1 infection and AIDS dementia complex
3. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
4. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients
5. Left ventricular structure and function in children infected with human immunodeficiency virus
6. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
7. Expression of inducible nitric oxide synthase in human heart failure
8. Expression and functional significance of tumor necrosis factor receptors in human myocadium
9. Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy
10. Heart muscle disease related to HIV infection: Prognostic implications
11. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus
12. Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine
13. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin-11
14. Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus
15. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophages-astroglia interactions: Implications for the neuropathogenesis of HIV disease
16. Proliferations of astrocytes in vitro in response to cytokines: A primary role for tumor necrosis factor
17. HIV displays its coat of arms
18. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
19. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex
20. Regulation of nitric oxide synthase in human immunodeficiency virus type 1-infected monocytes: Implications for HIV-associated neurological diseases
21. Neuronal apoptosis induced by HIV-1 tat protein and TNF-α: Potentiation of neurotoxicity by oxidative stress and implications for HIV-1 dementia
22. Cytokines in the brain during viral infection: Clues to HIV-associated dementia
23. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type-1 encephalopathy
24. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection
25. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumor necrosis factor-α and nitric oxide synthase
26. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997
27. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy
28. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998
29. Shift of prevalence and selected characteristic in HIV-1-related neurologic disorders in HAART era: Data from Italian Register Investigative Neuro AIDS (IRINA)
30. Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalization of infection
31. Cerebrospinal fluid HIV-RNA originates from both local CNS and systemic sources
32. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy